Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Real-World Study Evaluating the Impact of RISankizumab on BurdEn of Disease in Ulcerative Colitis in JaPan (RISE UP)

NCT07136116 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07136116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07136116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Real-World Study Evaluating the Impact of RISankizumab on BurdEn of Disease in Ulcerative Colitis in JaPan (RISE UP)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2025
Completion date
February 28, 2030
Enrollment
200 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis